CARMELINA Clinical Trial

CARMELINA was a randomized, placebo-controlled, multicenter, non-inferiority trial in adults with T2D and cardiovascular or renal risk factors. Read More “CARMELINA Clinical Trial”

Journal Watch: Continuous Glucose Monitoring and Risk of Hypoglycemia

May/June 2018: These papers summarize the recent progress in continuous glucose monitoring (CGM) measurements and interpretation, describe available CGM systems, address practical issues related to daily use and discuss proposed measures of glycemic control other than A1C. Read More “Journal Watch: Continuous Glucose Monitoring and Risk of Hypoglycemia”